Drug Profile
GPh 501
Alternative Names: GPh-501Latest Information Update: 18 Sep 2023
Price :
$50
*
At a glance
- Originator GEROPHARM
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Genitourinary disorders
Most Recent Events
- 18 Sep 2023 Discontinued - Preclinical for Genitourinary disorders in Russia (unspecified route) (GEROPHARM pipeline, September 2023)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Genitourinary-disorders in Russia
- 31 Aug 2016 Preclinical trials in Genitourinary disorders in Russia before August 2016 (GEROPHARM pipeline, August 2016)